Regional hyperthermic fibrinolytic perfusion after unsuccessful venous thrombectomy of extensive deep venous thrombosis

Journal of Vascular Surgery

Volumn 36, Issue 6, 2002, Pages 1219-1224

  Mumme, Achim ^a   Heinen, Wilfried ^b   Geier, Bruno ^a   Maatz, Winfried ^b   Barbera, Letterio ^a   Walterbusch, Gerhard ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b ST JOHANNES HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; APROTININ; HEPARIN;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERTHERMIC THERAPY; LUNG EMBOLISM; MALE; PEROPERATIVE COMPLICATION; PHLEBOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECANALIZATION; RECURRENT DISEASE; SCORING SYSTEM; TECHNIQUE; THROMBECTOMY; TREATMENT FAILURE; TREATMENT INDICATION; VEIN OCCLUSION; WOUND HEALING IMPAIRMENT;

EID: 0037003186     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.128296     Document Type: Article

References (33)

1. Mumme A, Ernst R, Kemen M, Walterbusch G, Zumtobel V. Regional hyperthermic fibrinolytic perfusion in postoperative deep venous thrombosis of the leg [in German]. Dtsch Med Wochenschr 1992;117:1637-42.
2. Marder VJ, Soulen RL, Atichartakarn V, Budzynski AZ, Parulekar S, Kim JR, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation ofstreptokinase and heparin therapy. J Lab Clin Med 1977;89:1018-29.
3. Porter JM, Moneta GL. An international consensus committee on chronic venous disease. Reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45.
4. Rogers LQ, Tutcher CL. Streptokinase therapy for deep vein thrombosis: a comprehensive rewiev of the English literature. Am J Med 1990; 88:389-95.
5. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993;36:359-64.
6. Arnesen H, Höiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982;211:65-8.
7. Wakefield TW. Treatment options for venous thrombosis. J Vasc Surg 2000;31:613-20.
8. Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R, et al. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. Chest 1990;97:172-5.
9. Plate G, Einarsson E, Ohlin P, Jensen P, Qvarfordt P, Eklöf B. Thrombectomy with temporary arteriovenous fistula: the treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1984;1:867-76.
10. Juhan CM, Alimi YS, Barthelemy PJ, Fabre DF, Riviere CS. Late results of iliofemoral venous thrombectomy. J Vasc Surg 1997;25:417-22.
11. Comerota AJ, Throm RC, Mathias SD, Haughton S, Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000;32:130-7.
12. Comerota AJ, Aldridge SA, Cohen G, Ball DS, Pliskin M, White JV. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary or catheter-directed thrombolysis. J Vasc Surg 1994;20:244-54.
13. Mewissen MW, Seabrook GR, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211:39-49.
14. Jae-Sung C, Martelli E, Mozes G, Miller VM, Gloviczki P. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg 1998;28:787-99.
15. Rhodes JM, Jae-Sung C, Gloviczki P, Mozes G, Rolle R, Miller VM. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000;31:1193-205.
16. Lin PH, Chen C, Surowiec SM, Conklin, B, Bush RL, Lumsden AB. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model. J Vasc Surg 2001;33:621-7.
17. Frenzel H, Hort W. Organization of experimental thrombi in arteries and veins. A comparative study [in German]. Basic Res Cardiol 1975; 70:480-94.
18. Creech O, Krementz ET, Ryan RF, Winblad JN. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958;148:616-32.
19. Minor DR, Allen RE, Alberts D, Yei-Mei Peng, Tardelli G, Hutchinson J. A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for limbs. Cancer 1985;55:2638-44.
20. Nachbur BB, Beck EA, Senn A. Can the results of treatment of deep venous thrombosis be improved by combining surgical thrombectomy with regional fibrinolysis? J Cardiovasc Surg 1980;21:347-52.
21. Mumme A, Kemen M, Ernst P, Zumtobel V. Locoregional ultrahigh dosage fibrinolysis of deep leg vein thrombosis [in German]. Vasa Suppl 1991;33:122-3.
22. Mumme A, Kemen M, Homann HH, Zumtobel V. The temperature dependence of fibrinolysis with streptokinase [in German]. Dtsch Med Wochenschr 1993;118:1594-6.
23. Mumme A, Senkal M, Kemen M, Zumtobel V. Temperature-dependency of the fibrinolysis with streptokinase and recombinant tissue-type plasminogen activator (rt-PA) [in German]. Onkologie 1995;18:195.
24. Geier B, Großefeld M, Barbera L, Mumme A. Pharmacokinetics of tissue plasminogen activator in an isolated extracorporeal circuit. J Vasc Surg 2001;33:165-9.
25. Clozel JP, Banken L, Roux S. Aprotinin: an antidote for recombinant tissue-type plasminogen activator (rt-PA) active in vivo. J Am Coll Cardiol 1990;16:507-10.
26. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72.
27. Capdeliva X, Calvet Y, Biboulet P, Biron C, Rubinovitch J, d'Athis F. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery. Anesthesiology 1998;88:50-7.
28. Ouriel K, Welch EL, Shortell CK, Geary K, Fiore WM, Cimono C. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vasc Surg 1995;22:593-97.
29. Marder VJ, Brenner B, Totterman S, Francis CW, Rubin R, Rao AK, et al. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis. J Lab Clin Med 1992;119:485-95.
30. Grimm W, Schwieder G, Wagner T. Fatal pulmonary embolism in venous thrombosis of the leg and pelvis during lysis therapy [in German]. Dtsch Med Wochenschr 1990;115:1583-7.
31. Thery C, Bauchard JJ, Lesenne M, Asseman P, Flajllet JG, Legghe R, et al. Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol 1992;69:117-22.
32. Monreal M, Martorell A, Callejas JM, Valls R, Llamazares IF, Lafoz E, et al. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective study. J Intern Med 1993;233:233-8.
33. Bounameaux H. Thrombolytic therapy: can it prevent the development of post-thrombotic syndrome? Fibrinolysis & Proteolysis 1998; 12(Suppl 2):31-7.